Готові списки джерел за темами / Breast Cancer Screening Policies

Добірка наукової літератури з теми "Breast Cancer Screening Policies"

Автор: Grafiati
Опубліковано: 6 вересня 2023

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Зміст

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Breast Cancer Screening Policies".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Breast Cancer Screening Policies"

1

Maillart, Lisa M., Julie Simmons Ivy, Scott Ransom, and Kathleen Diehl. "Assessing Dynamic Breast Cancer Screening Policies." Operations Research 56, no. 6 (December 2008): 1411–27. http://dx.doi.org/10.1287/opre.1080.0614.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Gocgun, Y., D. Banjevic, S. Taghipour, N. Montgomery, B. J. Harvey, A. K. S. Jardine, and A. B. Miller. "Cost-effectiveness of breast cancer screening policies using simulation." Breast 24, no. 4 (August 2015): 440–48. http://dx.doi.org/10.1016/j.breast.2015.03.012.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Urbain, J. L. "Breast cancer screening, diagnostic accuracy and health care policies." Canadian Medical Association Journal 172, no. 2 (January 18, 2005): 210–11. http://dx.doi.org/10.1503/cmaj.1041498.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Herrmann, Christian, Penelope Vounatsou, Beat Thürlimann, Nicole Probst-Hensch, Christian Rothermundt, and Silvia Ess. "Impact of mammography screening programmes on breast cancer mortality in Switzerland, a country with different regional screening policies." BMJ Open 8, no. 3 (March 2018): e017806. http://dx.doi.org/10.1136/bmjopen-2017-017806.

Повний текст джерела
Анотація:
IntroductionIn the past decades, mortality due to breast cancer has declined considerably in Switzerland and other developed countries. The reasons for this decline remain controversial as several factors occurred almost simultaneously, including important advances in treatment approaches, breast cancer awareness and the introduction of mammography screening programmes in many European countries. In Switzerland, mammography screening programmes (MSPs) have existed in some regions for over 20 years but do not yet exist in others. This offers the possibility to analyse its effects with modern spatiotemporal methodology. We aimed to assess the spatiotemporal patterns and the effect of MSPs on breast cancer mortality.SettingSwitzerland.ParticipantsThe study covers breast cancer deaths of the female population of Switzerland during the period 1969–2012. We retrieved data from the Swiss Federal Statistical Office aggregated on a small-area level.DesignWe fitted Bayesian hierarchical spatiotemporal models on death rates indirectly standardised by national references. We used linguistic region, degree of urbanisation, duration of population-based screening programmes and socioeconomic index as covariates.ResultsIn Switzerland, breast cancer mortality in women slightly increased until 1989–1992 and declined strongly thereafter. Until 2009–2012, the standardised mortality ratio declined to 57% (95% CI 54% to 60%) of the 1969–1972 value. None of the other coefficients of the spatial regressions had a significant effect on breast cancer mortality. In 2009–2012, no region had significantly elevated or reduced breast cancer mortality at 95% credible interval level compared with the national mean.ConclusionThere has been a strong reduction of breast cancer mortality from the 1990s onwards. No important spatial disparities were observed. The factors studied (urbanisation, language, duration of population-based MSP and socioeconomic characteristics) did not seem to have an influence on them. Low participation rates and opportunistic screening use may have contributed to the low impact of MSPs.
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Kong, Qingxia, Susana Mondschein, and Ana Pereira. "Effectiveness of breast cancer screening policies in countries with medium-low incidence rates." Revista de Saúde Pública 52 (January 29, 2018): 7. http://dx.doi.org/10.11606/s1518-8787.2018052000378.

Повний текст джерела
Анотація:
Chile has lower breast cancer incidence rates compared to those in developed countries. Our public health system aims to perform 10 biennial screening mammograms in the age group of 50 to 69 years by 2020. Using a dynamic programming model, we have found the optimal ages to perform 10 screening mammograms that lead to the lowest lifetime death rate and we have evaluated a set of fixed inter-screening interval policies. The optimal ages for the 10 mammograms are 43, 47, 51, 54, 57, 61, 65, 68, 72, and 76 years, and the most effective fixed inter-screening is every four years after the 40 years. Both policies respectively reduce lifetime death rate in 6.4% and 5.7% and the cost of saving one life in 17% and 9.3% compared to the 2020 Chilean policy. Our findings show that two-year inter-screening interval policies are less effective in countries with lower breast cancer incidence; thus we recommend screening policies with a wider age range and larger inter-screening intervals for Chile.
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Rajendram, Priyanka, Prachi Singh, Kok Teng Han, Vasuki Utravathy, Hwee Lin Wee, Anand Jha, Shyamala Thilagaratnam, and Swathi Pathadka. "Barriers to breast cancer screening in Singapore: A literature review." Annals of the Academy of Medicine, Singapore 51, no. 8 (August 29, 2022): 493–501. http://dx.doi.org/10.47102/annals-acadmedsg.2021329.

Повний текст джерела
Анотація:
Introduction: Breast cancer is a leading cause of cancer death among women, and its age-standardised incidence rate is one of the highest in Asia. We aimed to review studies on barriers to breast cancer screening to inform future policies in Singapore. Method: This was a literature review of both quantitative and qualitative studies published between 2012 and 2020 using PubMed, Google Scholar and Cochrane databases, which analysed the perceptions and behaviours of women towards breast cancer screening in Singapore. Results: Through a thematic analysis based on the Health Belief Model, significant themes associated with low breast cancer screening uptake in Singapore were identified. The themes are: (1) high perceived barriers versus benefits, including fear of the breast cancer screening procedure and its possible outcomes, (2) personal challenges that impede screening attendance and paying for screening and treatment, and (3) low perceived susceptibility to breast cancer. Conclusion: Perceived costs/barriers vs benefits of screening appear to be the most common barriers to breast cancer screening in Singapore. Based on the barriers identified, increasing convenience to get screened, reducing mammogram and treatment costs, and improving engagement with support groups are recommended to improve the screening uptake rate in Singapore. Keywords: Barriers, breast cancer, mammography, screening programme
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Yala, Adam, Peter G. Mikhael, Constance Lehman, Gigin Lin, Fredrik Strand, Yung-Liang Wan, Kevin Hughes, et al. "Optimizing risk-based breast cancer screening policies with reinforcement learning." Nature Medicine 28, no. 1 (January 2022): 136–43. http://dx.doi.org/10.1038/s41591-021-01599-w.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Madadi, Mahboubeh, Shengfan Zhang, and Louise M. Henderson. "Evaluation of breast cancer mammography screening policies considering adherence behavior." European Journal of Operational Research 247, no. 2 (December 2015): 630–40. http://dx.doi.org/10.1016/j.ejor.2015.05.068.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Seely, Jean M., Peter R. Eby, and Martin J. Yaffe. "The Fundamental Flaws of the CNBSS Trials: A Scientific Review." Journal of Breast Imaging 4, no. 2 (March 1, 2022): 108–19. http://dx.doi.org/10.1093/jbi/wbab099.

Повний текст джерела
Анотація:
Abstract Although the two Canadian National Breast Screening Study (CNBSS) trials were performed 40 years ago, their negative findings continue to heavily influence screening policies around the world. These policies, based on underestimates of the mortality reduction attributable to mammography particularly for women in the 40–49-year age range, contribute to increased mortality and morbidity from breast cancer. This review summarizes principles of a randomized controlled trial (RCT) and evaluates the compliance of the CNBSS1 and CNBSS2 RCTs in the context of these principles. We describe the fundamental flaws of the CNBSS trials, which failed to demonstrate mortality benefit of screening mammography and contribute to their being the only two outlier studies of eight screening mammography RCTs. The most significant flaws of the trials are (1) inadequate power to detect significant differences in breast cancer mortality; (2) very poor quality mammography with low sensitivity and cancer detection rates; (3) inclusion of women with symptoms of breast cancer; and (4) study design that allowed for violation of the randomization of the allocation process. Finally, we demonstrate that the conditions of the screening intervention in the CNBSS do not reflect the environment of modern population-based screening mammography programs.
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Halpern, Michael T., Melissa A. Romaire, Susan G. Haber, Florence K. Tangka, Susan A. Sabatino, and David H. Howard. "Impact of Medicaid reimbursement and eligibility policies on receipt of cancer screening." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): 6514. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.6514.

Повний текст джерела
Анотація:
6514 Background: State Medicaid programs cover receipt of cancer screening services. However, coverage of cancer screening tests does not guarantee access to these services. Medicaid beneficiaries are less likely to be screened for cancer and more likely to present with advanced stage cancers. State-specific variations in Medicaid program eligibility requirements and reimbursements for medical services may affect cancer screening rates among Medicaid enrollees. This study examined how eligibility and reimbursement policies affected receipt of breast, cervical, colorectal, and prostate cancer screening. Methods: We examined 2007 Medicaid data for individuals age 21-64 enrolled in fee-for-service Medicaid for at least 4 months from 46 states and the District of Columbia. We examined the association of state-specific Medicaid cancer screening test and office visit reimbursements, income and financial asset eligibility requirements, physician copayments, and frequency of Medicaid eligibility renewal on receipt of cancer screening. Analyses used multivariate logistic regressions with generalized estimating equations to control for correlation between beneficiaries within a state. Results: Increased Medicaid screening test reimbursements were significantly associated with small increases in receipt of colonoscopy, mammograms, and PSA tests. Increased reimbursements for office visits were associated with increased receipt of colonoscopy, FOBT, Pap tests, and mammograms. Greater asset thresholds for Medicaid eligibility increased the likelihood of all screening tests except FOBT. Beneficiaries in states requiring more frequent (<12 month) renewal of Medicaid eligibility were more likely to receive FOBT, PSA, or mammograms, but less likely to receive Pap tests. Conclusions: Increasing Medicaid reimbursement rates and asset policies was generally associated with increases in cancer screening. As proposed Medicaid eligibility expansions will almost certainly increase the number of enrollees in this program, it is crucial to provide adequate reimbursements and develop eligibility policies to promote cancer screening and thereby increase early cancer detection among this underserved population.
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Дисертації з теми "Breast Cancer Screening Policies"

1

Hann, A. P. "The politics of breast cancer screening." Thesis, University of East Anglia, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.309962.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Chen, Hsiu-Hsi. "Mathematical models for progression of breast cancer and evaluation of breast cancer screening." Thesis, University of Cambridge, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.388263.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Song, Ningning. "Quantitative photoacoustic tomography for breast cancer screening." Thesis, Ecole centrale de Marseille, 2014. http://www.theses.fr/2014ECDM0005/document.

Повний текст джерела
Анотація:
Ces travaux de thèse sont motivés par le développement de techniques d’imagerie alternatives pour le diagnostic précoce du cancer du sein. Parmi celles-ci, l’imagerie photoacoustique couple potentiellement les avantages de deux modalités d’imagerie non-invasives, à savoir la quantification de contrastes physiologiques du fait de l’excitation optique et la haute résolution du fait d’un sondage acoustique.Le but de ces travaux est de proposer une modélisation multiondes du phénomène photoacoustique, et d’incorporer ce modèle dans un algorithme de reconstruction efficace pour résoudre le problème inverse. Celui-ci se rapporte à la reconstruction de cartes de propriétés physiques (optique et/ou acoustiques) de l’intérieur du sein. La Méthode des Eléments Finis (MEF) a été retenue pour résoudre l’équation de propagation optique. Pour la résolution de l’équation de propagation acoustique, une méthode semi-analytique, basée sur des calculs par transformées de Fourier (méthod k-space), a été choisie. Pour la résolution du problème inverse, deux approches ont été étudiées : i) un sondage passif, permettant de remonter à la distribution de pression initiale, à l’aide de la méthode de retournement temporel ; ii) un sondage actif, où l’on interroge le milieu sélectivement sous différentes excitations, permettant de remonter quantitativement aux propriétés optiques du milieu. On appelle cette dernière approche Tomographie PhotoAcoustique Quantitative (TPAQ). Une étude spécifique sur le protocole d’illumination/détection a été conduite, prenant également en compte les contraintes expérimentales
The present work was motivated by the development of alternative imaging techniques for breast cancer early diagnosis, that is photoacoustic imaging, which potentially couples the merits of optical imaging and ultrasound imaging, that is high optical functional contrasts brought by optical probing and high spatial resolution by ultrasound detection. Our work aims at modeling the photoacoustic multiwave phenomenon and incorporate it in an efficient reconstruction algorithm to solve the inverse problem. The inverse problem consists in the recovery of interior maps of physical properties of the breast. The forward model couples optical and acoustic propagations. The Finite Element Method (FEM) was chosen for solving the optical propagation equation, while a semi-analytical method based on Fourier transforms calculations (k-space method) was preferred for solving the acoustic propagation equation. For the inverse model, time reversal method was adopted to reconstruct the initial pressure distribution, an active approach of the inverse problem was also achieved, which decoupled the optical properties from measured photoacoustic pressure, this approach is called quantitative photoacoustic tomography (QPAT), in this approach, illumination/detection protocol was studied, and the experimental set up is also take into consideration. In the last step, photoacoustic pressure measurements obtained from experiment and simulation are studied and compared
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Chang, Sue-Ling. "Breast cancer subtypes and screening mammography sensitivity." Thesis, Université Laval, 2014. http://www.theses.ulaval.ca/2014/30680/30680.pdf.

Повний текст джерела
Анотація:
Les cancers du sein peuvent être classifiés selon le statut de récepteur d’estrogène (RE), de récepteur de progestérone (RP), de récepteur HER2, ou selon quatre sous-types (Luminal A, Luminal B, HER2-enrichi, Triple-négatif) ayant des propriétés biologiques et cliniques différentes. La sensibilité du dépistage par mammographie pourrait varier selon ces types de cancers mais ceci n’est pas encore clair. L’agressivité de la tumeur, mesurée par le grade histologique pourrait expliquer cette association. Les types de cancers d’intervalle ont été comparés à ceux de cancers détectés par dépistage parmi 1536 cas infiltrants provenant d’un centre de référence de Québec. Les tumeurs RE-négatif, RP-négatif, HER2-positif, Luminal B, HER2-enrichi et TPN étaient tous plus fréquentes chez les femmes avec cancers d’intervalle que chez celles avec cancers détectés par dépistage. À l’exception des tumeurs HER2-positif et HER2-enrichi, le grade histologique expliquait en grande partie la variabilité observée entre les types de cancer et la sensibilité.
Breast cancers can be classified according to tumour estrogen (ER) and progesterone (PR) receptors, human epidermal growth factor receptor 2 (HER2), and according to four subtypes (Luminal A, Luminal B, HER2-enriched, Triple-negative), each with different biological and clinical profiles. These tumour types may also influence screening mammography sensitivity but this is still not clear. Tumour aggressiveness, measured by the histological grade, may also play a role in explaining this association. Interval cancer types were compared to screen-detected cancer types in 1536 invasive cases obtained from a reference center in Quebec. ER-negative, PR-negative and HER2-positive, Luminal B, HER2-enriched and TPN tumours were all more frequent in women with interval cancers than in women with screen-detected cancers. Except for HER2-positive and HER2-enriched tumours, histological grade explained most of the variability observed between tumour receptor status, subtypes and sensitivity.
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Puig, Vives Montserrat. "Breast cancer epidemiology: mammographic screening and molecular subtypes." Doctoral thesis, Universitat de Girona, 2015. http://hdl.handle.net/10803/289426.

Повний текст джерела
Анотація:
The aim of this thesis is to carry out an in-depth study of various aspects of breast cancer epidemiology. Firstly, we have confirmed that DCIS incidence in Girona has increased over recent decades. Proportions of screen-detected cancers, interval cancers and non-screen-detected cancers during the start-up phase of the mammographic screening programme were found to be 42.2%, 5.8% and 52.2%, respectively. Secondly, we have found that luminal A-like was the most frequent subtype associated with the best survival rate, while triple-negative breast cancer was related to the lowest survival rate. Importantly, we have concluded that breast cancer molecular subtype defined by IHC biomarkers provides prognostic value, regardless of age, tumour size, histological grade, lymph node involvement and method of detection. Finally, we have demonstrated that method of detection also provides prognostic value regardless of age, tumour size, histological grade, lymph node involvement and breast cancer molecular subtype defined by IHC biomarkers.
L’objectiu d’aquesta tesi és realitzar aprofundir en diversos aspectes de l'epidemiologia del càncer de mama. Hem confirmat que la incidència del DCIS a Girona ha augmentat en les últimes dècades. Les proporcions dels càncers detectats mitjançant el programa de cribratge, fora d’aquest i els càncers d'interval van ser del 42,2%, 52,2% i 5,8%, respectivament. Per altra banda, el subtipus amb la supervivència més elevada i més baixa van ser el luminal A-like i el triple negatiu, respectivament. És important destacar que el subtipus molecular de càncer de mama definit per biomarcadors determinats amb tècniques d’IHC proporciona valor pronòstic, independentment de l'edat, la mida, el grau histològic, l’afectació dels ganglis i el mètode de detecció. Finalment, hem demostrat que el mètode de detecció del càncer també proporciona valor pronòstic independentment de l'edat, la mida, el grau histològic, l'afectació dels ganglis i el subtipus molecular.
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Iliouchina, Natalia V. (Natalia Vladimirovna) 1979. "Models for the effectiveness of breast cancer screening." Thesis, Massachusetts Institute of Technology, 2001. http://hdl.handle.net/1721.1/86804.

Повний текст джерела
Анотація:
Thesis (M.Eng. and S.B.)--Massachusetts Institute of Technology, Dept. of Electrical Engineering and Computer Science, 2001.
Includes bibliographical references (leaf 72).
by Natalia V. Iliouchina.
M.Eng.and S.B.
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Hammond, Marsha V. "Breast Cancer Screening Health Behaviors in Older Women." Thesis, University of North Texas, 1994. https://digital.library.unt.edu/ark:/67531/metadc278973/.

Повний текст джерела
Анотація:
Health beliefs of 221 postmenopausal women were assessed to predict the Breast Cancer Screening Behaviors of breast self-examination (BSE) and utilization of mammography. Champion's (1991) revised Health Belief Model (HBM) instrument for BSE, which assesses the HBM constructs of Seriousness, Susceptibility, Benefits, Barriers, Confidence and Health Motivation, was utilized along with her Barriers and Benefits instrument for mammography usage. Ronis' and Harel's (1989) constructs of Severity-Late and Severity-Early were evaluated along with Cuing and demographic variables. These exogenous latent constructs were utilized in a LISREL path model to predict Breast Cancer Screening Behavior.
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Goldzahl, Léontine. "A behavioral approach to breast cancer screening decision." Thesis, Paris 1, 2015. http://www.theses.fr/2015PA010011.

Повний текст джерела
Анотація:
Cette thèse étudie les facteurs d’offre et de demande associés au recours au dépistage du cancer du sein. Parmi les facteurs d’offre, j’examine comment la coexistence du dépistage organisé au côté du dépistage individuel influence le contenu de l’examen de dépistage ainsi que le recours régulier au dépistage. En plus des facteurs de demande tels les caractéristiques socioéconomiques, une attention particulière est portée à la possibilité d’expliquer le recours régulier au dépistage par les préférences face au risque et temporelles ainsi que les perceptions. À partir de régularités psychologiques identifiées dans les travaux d’économie comportementale et de psychologie, trois interventions de type nudge sont testées dans le cadre d’une expérience randomisée sur le terrain visant à augmenter le taux de dépistage dans le programme national
This thesis explores supply and demand factors associated with the use of breast cancer screening. Among the supply factors, I examine how the coexistence of organized and opportunistic screenings influences the content of the screening exam and screening regularity. Besides the usual demand factors such as socioeconomic characteristics, a special attention is being given to the possibility of explaining screening regularly by individuals’ risk and time preferences and perceptions. Based on psychological patterns identified in the literature in behavioral economics and psychology, three nudge interventions are tested in a randomized field experiment to increase the national program uptake rate
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Patino, Patricia. "Breast cancer : relationship betweern acculturation and barriers to breast cancer screening in Southwest Florida Latinas." [Tampa, Fla] : University of South Florida, 2006. http://purl.fcla.edu/usf/dc/et/SFE0001867.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Patino, Patricia. "Breast cancer: Relationship between acculturation and barriers to breast cancer screening in Southwest Florida Latinas." Scholar Commons, 2006. http://scholarcommons.usf.edu/etd/2656.

Повний текст джерела
Анотація:
Despite multiple campaigns by the American Cancer Society, reports indicate that Latinas living in the United States who contract breast cancer are more likely than Anglos to die. These findings correlate with low participation in breast cancer screenings among Latinas. The objective of this study was to identify key obstacles that influence Latinas' low participation in breast cancer screenings, based on their health beliefs, knowledge of screenings, acculturation, and socio-economic factors.The study was a face-to-face informal interview, combined with a survey questionnaire conducted at churches, social clubs and/or at the participants' homes in a southwest Florida urban community. The sample consisted of a total of 50 women: all of the participants were Latinas 40 years of age and over; they had to be fluent in Spanish or English or both. A Spanish-English bilingual individual conducted a personal interview in the preferred language of each participant. The first part of the interview was to identify barriers that affect screenings. The second part used a survey to weigh the identified factors in order to determine their importance to the participants' health decisions. This study used a health belief model scale to evaluate women's beliefs about breast cancer, and the benefits of screenings.The research results revealed that Latinas who participated in this study were acculturated to the United States culture; the largest group of participants reported being from Colombia, followed by Cuba and Puerto Rico; only two of the participants were Mexican. Seventy-eight percent of the participants self- reported having yearly mammograms, and 74% performed monthly breast self examination BSE; 60% were bilingual; 68% had some kind of health insurance. These results differ from earlier studies from the western United States where the majority of Latinas were of Mexican or Central American origin. This suggested that Latinas from Southwest Florida are different from Latinas in other areas of the United States. A weak but significant correlation was found between acculturation and perceived barriers to breast cancer screenings, (r = 0.45, p = .01); Latinas who are more acculturated perceived more barriers than those who are less acculturated. There was not significant difference between participants who had health insurance and those who did not (t = 0.96, p = .35). The results of this study are significant for nurses and especially for advanced practice nurses, who can assess patients' knowledge about cancer in general, and breast cancer in particular when caring for Latinas; of particular concern should be the evaluation of patients' levels of acculturation, health beliefs, and understanding of the English language. Still the fundamental barrier to Latinas not bilingual in Spanish and English may be the lack of resources and information in Spanish.
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Книги з теми "Breast Cancer Screening Policies"

1

MRCGP, Humphreys John, Cancer Research Campaign (Great Britain), and National Breast Screening Programme (Great Britain), eds. Breast cancer screening. Oxford: Oxford University Press, 1988.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Royal Colleges of Physicians of the United Kingdom. Committee on Health Promotion. Screening for breast cancer. London: Faculty of Community Medicine of the Royal Colleges of Physicians of the United Kingdom, 1986.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Royal Colleges of Physicians of the United Kingdom. Committee on Health Promotion. Screening for breast cancer. London: The Colleges, 1987.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

E, Day N., and Miller A. B, eds. Screening for breast cancer. Toronto: Huber, 1988.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Elizabeth, Parvin, ed. Screening for breast cancer. Oxford: Oxford University Press, 2007.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

E, Day N., Miller, A. B. (Ed.), and International Union Against Cancer, eds. Screening for breast cancer. Bern: Hans Huber, 1988.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Farrow, Alexandra. Breast cancer screening thesaurus. Bristol: Health Care Evaluation Unit, Department of Epidemiology and Public Health Medicine, University of Bristol, 1991.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Gad, Adel, and Marco Rosselli Del Turco, eds. Breast Cancer Screening in Europe. Berlin, Heidelberg: Springer Berlin Heidelberg, 1993. http://dx.doi.org/10.1007/978-3-642-78154-4.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Shetty, Mahesh K., ed. Breast Cancer Screening and Diagnosis. New York, NY: Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4939-1267-4.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Breast cancer screening and prevention. Hauppauge, N.Y: Nova Science, 2011.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Частини книг з теми "Breast Cancer Screening Policies"

1

Holmberg, Lars. "The Impact of Breast Cancer Screening on Surgical Treatment Policies." In Fundamental Problems in Breast Cancer, 97–104. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4613-2049-4_12.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Madadi, Mahboubeh, and Shengfan Zhang. "COST-EFFECTIVENESS ANALYSIS OF BREAST CANCER MAMMOGRAPHY SCREENING POLICIES CONSIDERING UNCERTAINTY IN WOMEN'S ADHERENCE." In Decision Analytics and Optimization in Disease Prevention and Treatment, 223–40. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2018. http://dx.doi.org/10.1002/9781118960158.ch10.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Rennert, Gad. "Political Interpretation of Scientific Evidence — Case Study of Breast Cancer Screening Policies Around the World." In Tumor Prevention and Genetics, 140–48. Berlin, Heidelberg: Springer Berlin Heidelberg, 2003. http://dx.doi.org/10.1007/978-3-642-55647-0_13.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Moss, S. M. "Breast Cancer." In Cancer Screening, 143–70. Boca Raton: CRC Press, 2021. http://dx.doi.org/10.1201/9780429179587-10.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Selvi, Radhakrishna. "Breast Cancer Screening." In Breast Diseases, 15–19. New Delhi: Springer India, 2014. http://dx.doi.org/10.1007/978-81-322-2077-0_2.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

von Fournier, D., H. W. Anton, H. Junkermann, and G. Bastert. "Breast Cancer Screening." In Cancer Diagnosis, 78–87. Berlin, Heidelberg: Springer Berlin Heidelberg, 1992. http://dx.doi.org/10.1007/978-3-642-76899-6_9.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Chamberlain, J. "Screening for Breast Cancer." In Breast Cancer, 45–55. Berlin, Heidelberg: Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-83675-6_3.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Nelson, Heidi D. "Breast Cancer Screening." In Cancer and Aging Handbook, 125–38. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2013. http://dx.doi.org/10.1002/9781118312513.ch10.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Miller, Anthony B. "Breast Cancer Screening." In Epidemiologic Studies in Cancer Prevention and Screening, 263–76. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-5586-8_17.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Rockoff, Steven, and Joseph D. Calandra. "Breast Cancer Screening." In Ambulatory Gynecology, 1–20. New York, NY: Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-7641-6_1.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Breast Cancer Screening Policies"

1

Taghipour, S., D. Banjevic, N. Montgomery, and A. K. S. Jardine. "Modeling breast cancer progression and evaluating screening policies." In 2013 Annual Reliability and Maintainability Symposium (RAMS). IEEE, 2013. http://dx.doi.org/10.1109/rams.2013.6517766.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Novaes, Danyelle Santos, João Paulo Medrado Santos, Camille Teles Ferreira de Almeida, Dandara Rocha Ramos, and Manuela Santana Aguiar. "THE IMPACT OF THE COVID-19 PANDEMIC ON THE PERFORMANCE OF MAMMOGRAPHIES IN THE BRAZILIAN NORTHEAST: AN ECOLOGICAL STUDY." In Brazilian Breast Cancer Symposium 2022. Mastology, 2022. http://dx.doi.org/10.29289/259453942022v32s2023.

Повний текст джерела
Анотація:
Objective: The aim of this study was to evaluate breast cancer screening according to demographic data, year of completion, age group, and geographic distribution in the pandemic period. Methods: An ecological study was carried out using data collected by the Departamento de Informática do Sistema Único de Saúde (DATASUS). The study population included patients who underwent screening for breast cancer in northeastern Brazil between 2019 and 2021. Results: The National Cancer Institute recommends biannual breast cancer screening through mammography for women aged 50–69 years. However, in 2020, the COVID-19 pandemic generated consequences such as the withdrawal of patients from health services, interfering with the performance of preventive mammography. In northeastern Brazil, 879,903 mammograms were performed on female patients in 2019, a number that was reduced by 39.23% in 2020 (534,647) and 5.68% in 2021 (829,902). A drop was also found in the number of examinations per target audience, especially in the year 2020 (40.36%) when compared to the year 2019, with the age group 50–54 years having the largest reduction, with a drop of 40.05%. It was found that between 2019 and 2020, all northeastern states had a drop in the number of examinations performed, with the largest drop being in Sergipe (52.54%). Despite this, in 2021, some states showed an increase in the number of examinations performed when compared to 2019, with Piauí standing out (50.54%). Conclusion: In the COVID-19 pandemic, there was a decrease in breast cancer screening between the years 2019 and 2020 in northeastern Brazil, with a discrete rise in the number of examinations performed in some states in 2021. The youngest age group of the target audience was the most negatively impacted. Thus, the need to use these data to formulate public policies to encourage screening and reduce morbidity and mortality from breast cancer is evident.
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Silva, Antonio Márcio Teodoro Cordeiro, Liliane Emilly dos Santos Sousa, Camila de Assunção Martins, Bárbara de Magalhães Souza Gomes, Jacqueline Andréia Bernardes Leão Cordeiro, Fábio Silvestre Ataides, and Cesar Augusto Sam Tiago Vilanova Costa. "EARLY TRACKING THROUGH MAMMOGRAPHY IN BREAST CANCER DETECTION IN WOMEN IN BRAZIL FROM 2015 TO 2019: EPIDEMIOLOGICAL STUDY." In Abstracts from the Brazilian Breast Cancer Symposium - BBCS 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s2113.

Повний текст джерела
Анотація:
Objectives: To analyze the aspects of mammography in the early screening of breast cancer, in Brazil, from 2015 to 2019. Methodology: Descriptive epidemiological study, with secondary data extracted from the Department of Informatics of the Brazilian Unified Health System (DATASUS), through the Cancer Information System (SISCAN). Information related to mammography examinations was classified by place of care according to the clinical indication (screening or diagnosis), age group (70 years), previous mammography, high risk of breast cancer (BC), examination completion time, and the Breast Imaging Reporting and Data System (BI-RADS®), which classifies radiological findings as 0 (undefined), 1 (negative), 2 (benign), 3 (probably benign), 4 (suspect), 5 (highly suspicious), and 6 (diagnosed with cancer). Results: Between 2015 and 2019, 3,031,607 mammograms were performed in Brazil, of which 2,955,262 occurred by screening and 76,345 by clinical diagnostic indication. Among the screening mammograms, 63.2% were performed on women in the age group recommended by the Brazilian Ministry of Health (MS), from 50 to 69 years old. The previous history of this examination was confirmed by 2,300,995 women, where 17.5% were at high risk for BC. For the examination time, 1,396,105 mammograms took place within 30 days, and 775,971 and 859,531 over 60 days. BI-RADS was higher in category 2 (1,520,469 mammograms), followed by category 1 with 1,071,514 of mammograms, and in the target population recommended by the Brazilian Ministry of Health, the largest number of tests was concentrated in BI-RADS category 2 with 34.2%. Conclusion: Characterization of the main aspects involved in mammography, such as age, high risk, and among others, allows to infer that the early screening of BC when prioritized by public health policies, aiming at the promotion of women’s health, impacts on the early detection and the reduction of the incidence and mortality by BC in women in Brazil.
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Belluco, Rosana Zabulon Feijó, Camila Pinheiro Carvalho, Paulo Eduardo Silva Belluco, Júllia Eduarda Feijó Belluco, and Carmelia Matos Santiago Reis. "DUCTAL CARCINOMA IN SITU OF BREAST: CASES ANALYSIS IN AN ACADEMIC HOSPITAL IN THE FEDERAL DISTRICT." In XXIV Congresso Brasileiro de Mastologia. Mastology, 2022. http://dx.doi.org/10.29289/259453942022v32s1027.

Повний текст джерела
Анотація:
Introduction: Breast cancer is the most common malignant neoplasm in women, after skin cancer, and one of the leading causes of cancer death in women. Diagnosing it as a premalignant lesion or “in situ” becomes challenging in the current conjuncture. Ductal carcinoma in situ (DCIS) is a proliferation of malignant epithelial cells within the breast ducts. These cells have a predilection for the terminal duct lobular unit and are restricted to the basement membrane of the ducts. Through mammographic screening, it is possible to identify DCIS, which is responsible for about 20% of cancers detected by mammography. Objective: The aim of this study was to evaluate the clinical, radiological, anatomopathological, and therapeutic aspects of patients with DCIS of the breast treated at an academic hospital in Federal District, Brazil. Methods: Retrospective, cross-sectional, descriptive, and observational studies were carried out through the analysis of electronic medical records of cases of patients diagnosed with DCIS, treated at the Hospital Regional da Asa Norte (HRAN) (Brasília/Federal District/Brazil), from March 2014 to March 2020. Results: Of the 196 patients surgically treated for breast cancer, only 19 (9.69%) had a diagnosis of DCIS. The mean age was 52.9 years, and the greatest involvement was in the fourth decade, with 28.57% of cases being referred to palpation of a breast lump. Most patients were symptomatic (57.14%). Most mammograms were categorized as BI-RADS IV (47.36%), with clustered microcalcifications being the most frequent finding (42.85%). The concordance rate between preoperative and postoperative biopsies was 61.53%. Most tumors were categorized as luminal B (42.85%) on immunohistochemistry. Only 49.8% of the patients underwent conservative surgery, and the axillary evaluation by sentinel lymph node biopsy (SLNB) was fulfilled in 14.6%. Mastectomy was performed in 50.2% of cases and in this group 94.7%, there was also axillary surgery by SLNB. In 5% had lymph node microinvasion. Half of the analyzed patients underwent radiotherapy after surgery, and 57.14% underwent hormone therapy. Conclusion: The low rate of DCIS in the study (9.69%) and the involvement of the disease in women under 50 years of age lead us to question the scope and accessibility of the mammographic screening program in the Brazilian Health Unified System (SUS) users, treated at the HRAN. We still have high rates of mastectomy and axillary surgery in the treatment of DCIS. Axillary dissection should be discouraged and SLNB carried out in specific cases. Knowing women with DCIS is essential to design interventions with the purpose of directing public policies to the population at risk, enabling early diagnosis, and improving the effectiveness of treatment.
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Freitas, Alexandre Villela de, Lucas Stathiacos e. Castella, Carolina Abreu de Rezende, Ana Jéssily Camargo Barbosa, and Tânia Silva de Melo. "IMPORTANCE AND IMPACT OF ONLINE COURSES FOR TRAINING PRIMARY HEALTH CARE PROFESSIONALS IN THE SCREENING, IDENTIFICATION, AND MANAGEMENT OF MAMMALIAN PATHOLOGIES/BREAST CANCER." In Abstracts from the Brazilian Breast Cancer Symposium - BBCS 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s2033.

Повний текст джерела
Анотація:
Introduction: Brazil is currently living in a scenario of epidemiological transition in health. Simultaneous occurrence of diseases is common to those of developed and underdeveloped countries, thus, facing a major challenge in planning and managing efficient public health policies that cover ongoing transitions. The increase in life expectancy leads to an increase in the incidence of chronic-degenerative diseases such as cancer. The use of the Internet for lectures, courses, and questionnaires, due to agility, low cost, wide reach, and excellent use of responses has been demonstrated as an excellent tool for research and teaching. Objective: The aim of this study was to assess the importance and impact of conducting online training courses for primary health care professionals in the screening, identification, and management of breast diseases/ breast cancer. Methodology: This is all cross-sectional and descriptive, carried out through the selection of 80 physicians and 100 nurses from primary health care in the municipality of Foz do Iguaçu by virtual communication and link to attend the course with mastological content elaborated from the Mastology Treaty of the Brazilian Mastology Society. Online lecture was held by shared platform with later discussion and clarification, application of a virtual questionnaire on the perception of the importance of the lecture content in their daily activities, and assimilation of the content. The value of the answers to the questionnaire was determined according to the profession and time of graduation. Results: We observed a higher access among nursing professionals when compared with physicians, 46%×28%. The group of physicians, mean age of 39.7 years, ranging from 28 to 56 years, equally distributed between 3 and 5 years, 5 and 10 years, and more than 10 years were formed. Regarding nursing, the groups with mean age of 36.9 years, ranging from 23 to 57 years, predominantly professionals with more than 10 years were formed (60.9%). All participants found this study useful or very useful for their professional activities. We observed a performance higher than 75% in correct answers to the questions in 61% and 56% of medical professionals and nurses, respectively, and close to 80% with performance higher than 50% in both groups. Among themselves related to the lowest rate of correct answers were the exclusion of self-examination as a measure of prevention and the higher rate are the indications of breast ultrasound complementary to mammography. Conclusion: Online courses for primary care professionals can be considered a useful tool in the training process, with low cost, good results, and great acceptance.
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Faria, Tayana Moreira, Felipe Andreotta Cavagna, André Mattar, Jorge Yoshinori Shida, and Luiz Henrique Gebrim. "AVERAGE SURVIVAL ACCORDING TO THE CLINICAL STAGE IN 10,532 PATIENTS WITH BREAST CANCER TREATED BY THE BRAZILIAN UNIFIED HEALTH SYSTEM (SUS) FROM JANUARY 2011 TO DECEMBER 2019 AT PÉROLA BYINGTON HOSPITAL." In Scientifc papers of XXIII Brazilian Breast Congress - 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s1034.

Повний текст джерела
Анотація:
Introduction: The distribution of the different clinical stages of cancer in the population is of paramount importance not only to assess prognosis and therapy, but mainly to establish public health strategies and priorities. The prevalence of advanced cases in some populations shows the need for public assistance policies aimed at early detection for a rapid reduction in mortality. Unfortunately, reports in Brazil about the different realities of assistance in the Brazilian Unified Health System (SUS) are scarce. Objectives: To evaluate the distribution of the different clinical stages, and the mean 5-year survival of 10,532 breast cancer patients treated by SUS at Pérola Byington Hospital, from January 2011 to December 2016. Methods: A hospital-based observational cross-sectional study was conducted. The population consisted of women with breast cancer treated by SUS at Pérola Byington Hospital. The data were registered in the institution’s data collection system, based on the selection of all women diagnosed with breast cancer in the period from January 2011 to December 2016, and stratified by survival in relation to the initial clinical staging. Results: Our database consists of 620 patients in stage zero (DCIS), 2,479 patients in stage I, 3,998 in stage II, 3,082 in stage III and 353 patients in stage IV. The highest survival rate (98%) was observed in patients with ductal carcinoma in situ. In stage I patients, the 5-year survival rate was 94.7%. This result is slightly higher than that observed in stage II patients, where 90.6% of them had a survival of more than 5 years. In patients belonging to stages IIIA, IIIB and IIIC, the 5-year survival was 83%, 72% and 57%, respectively. Among the patients treated in stage IV, the 5-year survival rate was 55%. Conclusions: Among DCIS, 2% had recurrence and death within 5 years. Survival in patients belonging to stages I and II was 94.7% and 90.6%, respectively, which is very close, according to literature data. The survival of patients belonging to stages IIIA and IIIB exceeded 70%, indirectly showing the efficacy of locoregional and systemic therapy at SUS, which applies to stages IIIC and IV. These reports are unprecedented in the database of the Unified Health System of the Municipality of São Paulo, in a population that undergoes only opportunistic screening.
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Boone, John M. "Dedicated Breast CT for Breast Cancer Screening." In MEDICAL PHYSICS: Seventh Mexican Symposium on Medical Physics. AIP, 2003. http://dx.doi.org/10.1063/1.1615091.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Demigha, Souad. "Data mining for breast cancer screening." In 2015 10th International Conference on Computer Science & Education (ICCSE). IEEE, 2015. http://dx.doi.org/10.1109/iccse.2015.7250219.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Cruz, Alexandra La, Carlos Andres Diaz Santacruz, Leisson Polo, and Erika Severeyn. "Breast Cancer Screening Using Deep Learning." In 2022 IEEE Sixth Ecuador Technical Chapters Meeting (ETCM). IEEE, 2022. http://dx.doi.org/10.1109/etcm56276.2022.9935747.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Karlsson, Andreas, Niten Olofsson, Erwin Laure, and Mark Clements. "A parallel microsimulation package for modelling cancer screening policies." In 2016 IEEE 12th International Conference on e-Science (e-Science). IEEE, 2016. http://dx.doi.org/10.1109/escience.2016.7870915.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Звіти організацій з теми "Breast Cancer Screening Policies"

1

Greenberg, Robert, and Patricia Carney. Regional Breast Cancer Screening Network. Fort Belvoir, VA: Defense Technical Information Center, September 2000. http://dx.doi.org/10.21236/ada394136.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Alfano, Robert R. Breast Cancer Screening Using Photonic Technology. Fort Belvoir, VA: Defense Technical Information Center, September 2001. http://dx.doi.org/10.21236/ada399367.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Boone, John M. Computer Simulation of Breast Cancer Screening. Fort Belvoir, VA: Defense Technical Information Center, July 1999. http://dx.doi.org/10.21236/ada383107.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Alfano, Robert R. Breast Cancer Screening Using Photonic Technology. Fort Belvoir, VA: Defense Technical Information Center, September 1999. http://dx.doi.org/10.21236/ada384638.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Wang, Joseph. Miniaturized DNA Biosensor for Decentralized Breast-Cancer Screening. Fort Belvoir, VA: Defense Technical Information Center, June 2001. http://dx.doi.org/10.21236/ada395007.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Wang, Joseph. Miniaturized DNA Biosensor for Decentralized Breast-Cancer Screening. Fort Belvoir, VA: Defense Technical Information Center, June 2002. http://dx.doi.org/10.21236/ada406787.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Wang, Joseph. Miniaturized DNA Biosensor for Decentralized Breast-Cancer Screening. Fort Belvoir, VA: Defense Technical Information Center, June 2004. http://dx.doi.org/10.21236/ada426440.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Wang, Joseph. Miniaturized DNA Biosensor for Decentralized Breast-Cancer Screening. Fort Belvoir, VA: Defense Technical Information Center, June 2003. http://dx.doi.org/10.21236/ada418130.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Fort, Jane G., and Nasar U. Ahmed. Empowering Factors Among Breast Cancer Screening Compliant Underserved Populations. Fort Belvoir, VA: Defense Technical Information Center, October 2005. http://dx.doi.org/10.21236/ada443597.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Ahmed, Nasar U. Empowering Factors Among Breast Cancer Screening Compliant Underserved Populations. Fort Belvoir, VA: Defense Technical Information Center, October 2001. http://dx.doi.org/10.21236/ada398988.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Також вас можуть зацікавити розширені добірки на тему "Breast Cancer Screening Policies" для конкретних типів джерел:
Статті в журналах Дисертації Книги
Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!

До бібліографії